Ainos (STU:FZX0) Valuation Rank


STU:FZX0 Ainos Inc STU:FZX0
24 GF Score
Price €12.50
GF Value €0.90
! 9 Warning Signs
View Full Analysis

What is Ainos Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ainos Valuation Rank Related Terms

STU:FZX0
24GF Score
Ainos Inc STU:FZX0
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ainos (STU:FZX0) Overvalued in 2026?

Based on GuruFocus' analysis, Ainos stock appears to be overvalued. The current stock price of €12.50 is trading 1288.9% above its estimated GF Value™ of €0.90.

Key valuation signals for STU:FZX0:

  • Valuation Rank:
  • GF Value™: €0.90 vs. price of €12.50 (1288.9% above fair value)
  • GF Score™: 24/100 with 9 warning signs

No single metric tells the full story. See the STU:FZX0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ainos Business Description

Other Exchanges AIMD:USA
Address 3050 Post Oak Boulevard, Suite 510-T80, Houston, TX, USA, 77056
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
24GF Score

Get the complete analysis for STU:FZX0

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.50
Price
€0.90
GF Value